Skip to main content
Premium Trial:

Request an Annual Quote

Consider It Judah Folkman's Last Gift

Over at Periodic Tabloid, Tom Tritton blogs about the potential resurrection of a promising anti-cancer drug compound known as TNP-470. While it was once considered "a miracle drug in the making," Tritton writes, the compound proved to be neurotoxic. But a new paper in Nature Biotech -- the late Judah Folkman is senior author -- suggests that "hooking the drug to nanopolymeric micelles" keeps all the upside of the compound while shedding the toxicity problems (in mice, anyway). GTO will keep its fingers crossed.


The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.